Diabetes Mellitus
Conditions
Interventions
Administration of Telmisartan or Telmisartan /Ca antagonist combination drug
Sponsors
Chiba University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with type2 diabetes or dyslipidemia or hypertension who are high risk for cardiovascular disease. 2.Age between 20 and 70 years 3.Patients who had administrated with Statin for more than 3 months and their LDL-C levels are below 120mg/dl
Exclusion criteria
Exclusion criteria: The exclusion criteria were an age >70 years, current history of myocardial infarction and/or cerebral stroke, uncontrollable hypertension (diastolic pressure > 180mmHg) and hyperglycemia (HbA1c > 9.0%), renal failure (serum creatinin > 3.0mg/dL), abnormal liver or muscle enzymes (ALT>100 or ALT>100), patients who applied for other clinical trial within 3 months, expectant mother, lactating woman, patients who had taken ACE-I, thiazolidine and fibrate, inappropriate patients judged by the physician in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum lipid (low density lipoprotein cholesterol) | — |
Countries
Japan
Contacts
Public Contactminoru takemoto
Chiba University Hospital Department of Medicine, Division of Diabetes, Metabolism and Endocrinology
Outcome results
None listed